$81.39
1.051.3%
Last update: Nov 12, 4:23 PM
DexCom Inc
DXCMNASDAQ
DexCom rose 34.8% from $59.61 to $80.35, ahead of the S&P 500's +10.8%. Its worst day was Oct 21 (−6.4%), and its low came Apr 29 at $57.56.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.68 beat the $0.65 estimate on $1.3B revenue (est. $1.3B); FY revenue guidance of $5.2B–$5.3B against the $5.0B consensus.
+7.6% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
EPS of $0.56 beat the $0.47 estimate on $1.2B revenue (est. $1.2B); FY revenue guidance of $5.2B–$5.3B against the $5.2B consensus.
+3.0% · S&P 500 +0.3%
DexCom shares rose 6.7%, while the S&P 500 rose 1.0%.
+6.7% · S&P 500 +1.0%
DexCom shares rose 7.2%, while the S&P 500 fell 0.5%.
+7.2% · S&P 500 −0.5%
EPS of $0.70 beat the $0.61 estimate on $1.3B revenue (est. $1.3B); FY revenue guidance of $5.2B–$5.3B against the $5.2B consensus.
+12.0%, the year's best day · S&P 500 +0.7%
DexCom closed at its highest level of the year, 54.9% above where the year started.
+2.3% · S&P 500 +0.4%
DexCom shares fell 6.4%, while the S&P 500 rose 0.5%.
−6.4%, the year's worst day · S&P 500 +0.5%
EPS of $0.73 beat the $0.67 estimate on $1.3B revenue (est. $1.3B); FY revenue guidance of $5.2B–$5.3B against the $5.2B consensus.
+3.0% · S&P 500 −1.8%
Where it ended: a close of $80.34 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 11, 2027 (EPS est. $0.72, revenue est. $1.4B).
Nothing in the past 12 months.
All DXCM dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for DXCM and SPY from Benzinga historical bars. Not investment advice.
